Clinical Trial Update: Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Envafolimab with Endostatin in recurrent or metastatic MSS-type colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Endostatin (endostatin)
• Envafolimab (envafolimab)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Colorectal Neoplasms | Phase 2 | Status: UNKNOWN